Catalyst Wire Dossier Catalyst Wire Dossier

AXS-02

· Axsome Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AXS-02, covering 2018-03-23 to 2019-01-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions [Phase 3]

See pricing